Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, is now offering services in Nagoya, Japan. The Nagoya site will provide in-country manufacture of highly potent oral solid dosage forms. It will also provide gateway services into Japan—inspection, packaging and testing—for highly potent oral solid drugs and sterile injectables made by Pfizer CentreOne outside the country. “We’re pleased to add Pfizer’s Nagoya facility to our manufacturing footprint,”...